Is Delcath Systems, Inc. overvalued or undervalued?
As of October 17, 2025, Delcath Systems, Inc. is considered overvalued with a valuation grade of expensive, indicated by a high Price to Book Value of 7.11, an EV to Sales ratio of 9.50, and a P/E ratio of 68.06, significantly exceeding its peers.
As of 17 October 2025, the valuation grade for Delcath Systems, Inc. has moved from fair to expensive, indicating a shift towards overvaluation. The company is considered overvalued based on its high Price to Book Value of 7.11 and an EV to Sales ratio of 9.50, both of which significantly exceed typical industry benchmarks. Additionally, the EV to Capital Employed ratio stands at 23.86, further supporting the notion of overvaluation relative to its peers.In comparison to its peers, Delcath Systems has a P/E ratio of 68.06, which is considerably higher than iCAD, Inc. at -19.65 and Eargo, Inc. at -0.61, both of which are classified as risky. This stark contrast highlights the potential overvaluation of Delcath Systems in the current market. Although return data is not available, the company's recent price movements suggest volatility, reinforcing the concerns regarding its valuation.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
